(Q33495905)

27 July 2017

1 reference

title

Diverse hematologic effects of parvovirus B19 infection (English)

1 reference

27 July 2017

Mustafa MM

1

1 reference

27 July 2017

McClain KL

series ordinal

2

1 reference

27 July 2017

publication date

1 June 1996

1 reference

Pediatric Clinics of North America

27 July 2017

published in

1 reference

27 July 2017

volume

43

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

809-821

1 reference

Experimental parvoviral infection in humans

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Human parvovirus, the cause of erythema infectiosum (fifth disease)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Candidate recombinant vaccine for human B19 parvovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Parvovirus B19-associated hemophagocytic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Academy rash. A probable epidemic of erythema infectiosum ('fifth disease').

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Molecular, cellular and clinical aspects of parvovirus B19 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Rapid and sensitive method for the detection of B19 virus DNA using the polymerase chain reaction with nested primers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Parvovirus-like particles in human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Parvovirus-associated thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Childhood transient erythroblastopenia complicated by thrombocytopenia and neutropenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Lack of evidence for parvovirus B19 viraemia in children with chronic neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Chronic neutropenia during childhood. A 13-year experience in a single institution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Acute hepatic sequestration caused by parvovirus B19 infection in a patient with sickle cell anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Chronic bone marrow failure due to persistent B19 parvovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Erythema infectiosum. An elementary school outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Peripheral thrombocytopenia in human parvovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Parvovirus and idiopathic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Human parvoviruses: implications for transfusion medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Electron microscopic identification of parvovirus virions in erythroid and granulocytic-line cells in a patient with human parvovirus B19 induced pancytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Parvovirus B19 associated with pseudoappendicitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

A human parvovirus-like virus inhibits haematopoietic colony formation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Human parvovirus B19-associatedarthritis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Replication of the B19 parvovirus in human bone marrow cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Parvovirus infections and hypoplastic crisis in sickle-cell anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Human parvovirus induced cytopenias: a report of five cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

B19 parvovirus replicates in erythroid leukemic cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Parvovirus B19-associated haemophagocytosis in Evans syndrome: aplastic crisis accompanied by severe thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Human parvovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Human parvovirus B19 encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

HUMAN PARVOVIRUS ARTHROPATHY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Transient erythroblastopenia of childhood due to human parvovirus B19 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Human parvovirus B19 infection during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Congenital parvovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Thrombocytopenia induced by human parvovirus B19 infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

The immune system as mediator of virus-associated bone marrow failure: B19 parvovirus and Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

Role of parvovirus B19 in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Human parvovirus B19 infection among hospital staff members after contact with infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970434-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70434-X

1 reference

27 July 2017

1 reference